ArticleTranslational lung cancer research2022

Safety and efficacy of retreatment with immune checkpoint inhibitors in non-small cell lung cancer: a systematic review and meta-analysis.

Zijing Cai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.